13.47
6.50%
-0.94
Rocket Pharmaceuticals Inc (RCKT) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
6.47%
67.38
|
63.28 | 65.43 | 68.76 | 62.19 |
Interest Income/Expense |
0.21%
0.471
|
0.47 | 0.469 | 0.468 | 0.468 |
Operating Income/Loss |
6.47%
-67.38
|
-63.28 | -65.43 | -68.76 | -62.19 |
Income/Loss From Continuing Operations Before Tax |
4.01%
-62.05
|
-59.66 | -61.90 | -65.70 | -58.34 |
Income/Loss From Continuing Operations After Tax |
4.01%
-62.05
|
-59.66 | -61.90 | -65.70 | -58.34 |
Net Income/Loss
|
4.01%
-62.05
|
-59.66 | -61.90 | -65.70 | -58.34 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,876%
93.55
|
3.1433 | 82.64 | 80.47 | 79.45 |
Diluted Average Shares |
2,876%
93.55
|
3.1433 | 82.64 | 80.47 | 79.45 |
Basic Earnings Per Share |
6.45%
-0.66
|
-0.62 | -0.75 | -0.82 | -0.73 |
Diluted Earnings Per Share |
6.45%
-0.66
|
-0.62 | -0.75 | -0.82 | -0.73 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):